Exploring the potential of cellular thermal shift assay (CETSA) to study drug resistance during cancer therapy

被引：1
|
作者：
Kunjamma, Lekshmy
Sreekumar, Usha
Lim, Yan Ting
Veerappan, Saranya
Nordlund, Par
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2045
引用
收藏
页数：2
相关论文
共 50 条
  • [31] USP24 promotes drug resistance during cancer therapy
    Wang, Shao-An
    Young, Ming-Jer
    Wang, Yi-Chang
    Chen, Shu-Hui
    Liu, Chia-Yu
    Lo, Yao-An
    Jen, Hung-Hsiang
    Hsu, Kai-Cheng
    Hung, Jan-Jong
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (09): : 2690 - 2707
  • [32] The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?
    Sebens, Susanne
    Schaefer, Heiner
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (11) : 2259 - 2272
  • [33] Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance
    Feng, Mei
    Santhanam, Ramesh Kumar
    Xing, Huan
    Zhou, Mingsheng
    Jia, Hui
    BIOCHEMICAL PHARMACOLOGY, 2024, 220
  • [34] The future of cancer therapy: exploring the potential of patient-derived organoids in drug development
    Avci, Cigir Biray
    Bagca, Bakiye Goker
    Shademan, Behrouz
    Takanlou, Leila Sabour
    Takanlou, Maryam Sabour
    Nourazarian, Alireza
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [35] Exploring the Potential of Mitochondria-Targeted Drug Delivery for Enhanced Breast Cancer Therapy
    Ghazizadeh, Yalda
    Sharifi-Ardani, Seyedeh Elnaz
    Tajik, Negin
    Mirzaei, Roya
    Pourahmad, Jalal
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2025, 2025 (01)
  • [36] Drug Target Engagement Using Coupled Cellular Thermal Shift Assay-Acoustic Reverse-Phase Protein Array
    Herledan, Adrien
    Andres, Marine
    Lejeune-Dodge, Aurore
    Leroux, Florence
    Biela, Alexandre
    Piveteau, Catherine
    Warenghem, Sandrine
    Couturier, Cyril
    Deprez, Benoit
    Deprez-Poulain, Rebecca
    SLAS DISCOVERY, 2020, 25 (02) : 207 - 214
  • [37] Drug-induced DNA hypermethylation: A potential mediator of acquired drug resistance during cancer chemotherapy
    Nyce, JW
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 386 (02) : 153 - 161
  • [38] Novel mass spectrometric assay for monitoring drug resistance in hepatitis B virus during lamivudine therapy
    Kim, NK
    Hwang, SG
    Hong, SP
    Rhee, H
    Chung, HJ
    Kim, S
    Han, JH
    Kim, HT
    Rim, KS
    Kang, MS
    Yoo, W
    Kim, SO
    KOREAN JOURNAL OF GENETICS, 2003, 25 (01): : 63 - 75
  • [39] Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
    Li, Qing-Hai
    Wang, Ying-Zhao
    Tu, Jian
    Liu, Chu-Wei
    Yuan, Yu-Jie
    Lin, Run
    He, Wei-Ling
    Cai, Shi-Rong
    He, Yu-Long
    Ye, Jin-Ning
    GASTROENTEROLOGY REPORT, 2020, 8 (03): : 179 - 191
  • [40] A computational study of combination HIFU–chemotherapy as a potential means of overcoming cancer drug resistance
    Ghasemi, Maryam
    Sivaloganathan, Sivabal
    Ghasemi, Maryam (m23ghase@uwaterloo.ca), 1600, Elsevier Inc. (329):
12345